BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19139309)

  • 1. Continued disease activity in a patient with multiple sclerosis after allogeneic hematopoietic cell transplantation.
    Lu JQ; Storek J; Metz L; Yong VW; Stevens AM; Nash RA; Joseph JT
    Arch Neurol; 2009 Jan; 66(1):116-20. PubMed ID: 19139309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Multiple Sclerosis-Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature.
    Das J; Gill A; Lo C; Chan-Lam N; Price S; Wharton SB; Jessop H; Sharrack B; Snowden JA
    Front Immunol; 2020; 11():668. PubMed ID: 32431694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic graft-versus-host disease after hematopoietic cell transplantation presenting as an acute hepatitis.
    Malik AH; Collins RH; Saboorian MH; Lee WM
    Am J Gastroenterol; 2001 Feb; 96(2):588-90. PubMed ID: 11232714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late onset membranous nephropathy complicating donor lymphocyte infusion for leukaemia relapse after allogeneic stem cell transplantation.
    Lam MF; Au WY; Tse KC; Chan TM; Chan GS; Chan KW; Lai KN
    Am J Hematol; 2007 Apr; 82(4):327-8. PubMed ID: 17177190
    [No Abstract]   [Full Text] [Related]  

  • 5. Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis.
    McAllister LD; Beatty PG; Rose J
    Bone Marrow Transplant; 1997 Feb; 19(4):395-7. PubMed ID: 9051253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal outcome in a patient developing Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD) without measurable disease.
    Ringhoffer M; Döhner K; Scheil S; Wilts H; Mertens T; Grimminger W; Döhner H; Bunjes D
    Bone Marrow Transplant; 2001 Sep; 28(6):615-8. PubMed ID: 11607777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
    Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
    Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Ataergin S; Arpaci F; Cetin T; Guran S; Yakicier C; Beyzadeoglu M; Ozet A
    Am J Hematol; 2006 May; 81(5):370-3. PubMed ID: 16628734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients.
    Burke MJ; Trotz B; Luo X; Weisdorf DJ; Baker KS; Wagner JE; Verneris MR
    Bone Marrow Transplant; 2009 Aug; 44(3):169-74. PubMed ID: 19204709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BK virus nephropathy after allogeneic stem cell transplantation: a case report and literature review.
    Lekakis LJ; Macrinici V; Baraboutis IG; Mitchell B; Howard DS
    Am J Hematol; 2009 Apr; 84(4):243-6. PubMed ID: 19208419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological complications of hematopoietic cell transplantation.
    Saiz A; Graus F
    Semin Neurol; 2004 Dec; 24(4):427-34. PubMed ID: 15637654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of allogeneic bone marrow transplantation to arrest disease activity in multiple sclerosis.
    Jeffery DR
    Mult Scler; 2007 Sep; 13(8):1071-5. PubMed ID: 17623737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system immune reconstitution inflammatory syndrome (IRIS) after hematopoietic SCT.
    Airas L; Päivärinta M; Röyttä M; Karhu J; Kauppila M; Itälä-Remes M; Remes K
    Bone Marrow Transplant; 2010 Mar; 45(3):593-6. PubMed ID: 19684631
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse.
    Yakoub-Agha I; Saule P; Magro L; Cracco P; Duhamel A; Coiteux V; Bruno B; Dufossé F; Jouet JP; Dessaint JP; Labalette M
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):496-504. PubMed ID: 19285638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis.
    Shevchenko YL; Novik AA; Kuznetsov AN; Afanasiev BV; Lisukov IA; Kozlov VA; Rykavicin OA; Ionova TI; Melnichenko VY; Fedorenko DA; Kulagin AD; Shamanski SV; Ivanov RA; Gorodokin G
    Exp Hematol; 2008 Aug; 36(8):922-8. PubMed ID: 18468768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant adenovirus hepatitis after allogeneic bone marrow transplantation.
    Bertheau P; Parquet N; Ferchal F; Gluckman E; Brocheriou C
    Bone Marrow Transplant; 1996 Feb; 17(2):295-8. PubMed ID: 8640184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
    Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
    Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
    Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete vaginal obstruction with hematometra after hematopoietic stem cell transplantation for chronic myeloid leukemia: a case report.
    Rodolakis A; Thomakos N; Harhalakis N; Iconomou T; Antsaklis A
    J Reprod Med; 2007 Oct; 52(10):959-61. PubMed ID: 17977175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.